TruVenturo operates as a company builder and venture investor, strategically partnering with promising small and medium-sized enterprises (SMEs). They focus on identifying, building, and supporting companies that shape the future of technology. Their approach involves hands-on support from the initial idea to market leadership, focusing on strategy, talent acquisition, capital allocation, and operational excellence. They also make strategic investments in high-potential companies operating in internet, B2B software, neuroscience, and longevity biotech sectors. The firm's vision is to build companies with real impact by developing ventures that redefine industries and create lasting value. They combine deep sector expertise with hands-on execution to empower founders and teams to build market leaders. Their in-house team covers technology, product development, sales, marketing, human resources, finance, and legal aspects, guiding ventures towards sustainable success. TruVenturo emphasizes building alongside founders, offering extensive experience, a global network, and deep sector knowledge in technology, healthcare, and B2B. They prioritize creating real-world impact and long-term value. Founded by Nils Regge, a serial entrepreneur with experience in health and biotech, TruVenturo emphasizes a strong collaborative relationships with industry leaders. Nils has a track record of founding businesses and successful exits including taking HomeToGo public via SPAC IPO.
Preferred startup development maturity for initial funding deployment.
Tech platforms, B2B software, Bio & Frontier Tech, Neuroscience, Longevity Biotech, Internet
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...